Complement activation in severe Plasmodium falciparum malaria. 1997

C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
Internal Medicine I, University of Vienna, Vienna, Austria.

We determined indices of plasma complement activation (C3, C4, Bb, C4d, iC3b, and SC5b-9), levels of tumor necrosis factor (TNF) and interleukin-6, and the APACHE II score in 23 patients with complicated Plasmodium falciparum malaria. On admission, plasma concentrations of Bb, SC5b-9, and C4d were markedly increased compared to healthy control subjects (n = 24) (4.5 +/- 1.9 vs 1.5 +/- 0.6 mg/L; 1125.7 +/- 496.9 vs 183.2 +/- 76.5 microg/L; and 15.7 +/- 5.7 vs 7.2 +/- 1.4 mg/L, P < 0.01 for all). In contrast C3 and iC3b concentrations were decreased (631.4 +/- 247 vs 947.3 +/- 243.2 and 105 +/- 17.9 vs 151.3 +/- 14.5 mg/L; P < 0.01 for both). Plasma C4 concentrations in malaria were not different from normal controls. Plasma Bb, C3, and iC3b levels normalized on day 7 of treatment, whereas SC5b-9 and C4d levels remained elevated. A significant correlation between elevated TNF levels and Bb (r = 0.507) and SC5b-9 (r = 0.448, P < 0.01 for both) and a negative correlation between iC3b and SC5b-9 and TNF levels existed (r = -0.537 and r = -0.466, P < 0.01 for both). In addition, a significant correlation between C3 and iC3b (r = 0.689) and C4 and C4d (r = 0.737) existed. However, no relation between clinical disease severity and complement fragments existed. The results demonstrate that both the classical and the alternative pathways of the complement system are profoundly activated in complicated malaria.

UI MeSH Term Description Entries
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011415 Complement Factor B A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb. C3 Proactivator,C3PA,Complement 3 Proactivator,Factor B,Properdin Factor B,Bb Fragment of Factor B,Complement Factor B Fragment, Bb,Complement Factor B, Alternative Pathway,Complement Factor B-Derived Fragment Bb,Complement Factor Ba,Complement Factor Bb,Complement Protein B,Complement Protein Factor B,Properdin Factor Ba,Properdin Factor Bb,Properdin Factor Bf,Properdin Factor Bf F1,Bb, Complement Factor,Complement Factor B Derived Fragment Bb,Factor B, Complement,Factor B, Properdin,Factor Ba, Complement,Factor Ba, Properdin,Factor Bb, Complement,Factor Bb, Properdin,Factor Bf, Properdin,Proactivator, C3,Proactivator, Complement 3,Protein B, Complement
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003179 Complement C3b The larger fragment generated from the cleavage of COMPLEMENT C3 by C3 CONVERTASE. It is a constituent of the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb), and COMPLEMENT C5 CONVERTASES in both the classical (C4b2a3b) and the alternative (C3bBb3b) pathway. C3b participates in IMMUNE ADHERENCE REACTION and enhances PHAGOCYTOSIS. It can be inactivated (iC3b) or cleaved by various proteases to yield fragments such as COMPLEMENT C3C; COMPLEMENT C3D; C3e; C3f; and C3g. C3b Complement,C3bi,Complement 3b,Complement Component 3b,Inactivated C3b,iC3b,C3b, Complement,C3b, Inactivated,Complement, C3b,Component 3b, Complement
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
December 2007, Malaria journal,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
September 2011, Revista Brasileira de terapia intensiva,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
January 2009, Malaria journal,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
November 2010, Medicina intensiva,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
January 2013, The Journal of infectious diseases,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
January 2000, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
April 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
June 2008, The Lancet. Infectious diseases,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
December 1998, The American journal of tropical medicine and hygiene,
C Wenisch, and S Spitzauer, and K Florris-Linau, and H Rumpold, and S Vannaphan, and B Parschalk, and W Graninger, and S Looareesuwan
January 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!